CIK: 0001595851 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value: $481M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | CLOVIS ONCOLOGY INC | 301,000 | $28.18M | 5.9% | $93.63 | $16.16 | — | Call | 189464100 |
| XBI | SPDR SERIES TRUST | 350,000 | $27.01M | 5.6% | $77.18 | — | — | Put | 78464A870 |
| — | PORTOLA PHARMACEUTICALS INC | 400,000 | $22.47M | 4.7% | $56.17 | $39.19 | — | Put | 737010108 |
| BMY | BRISTOL MYERS SQUIBB CO | 300,000 | $16.75M | 3.5% | $55.82 | — | — | Call | 110122108 |
| — | AVEXIS INC | 190,000 | $15.61M | 3.2% | $82.16 | $49.54 | — | COM | 05366U100 |
| — | SEATTLE GENETICS INC | 300,000 | $15.52M | 3.2% | $51.74 | $54.11 | — | COM | 812578102 |
| — | DBV TECHNOLOGIES S A | 425,000 | $15.18M | 3.2% | $35.71 | $35.76 | — | SPONSORED ADR | 23306J101 |
| PBYI | PUMA BIOTECHNOLOGY INC | 150,000 | $13.11M | 2.7% | $87.40 * | $36.49 | +53.3% | COM | 74587V107 |
| MRK | MERCK & CO INC | 200,000 | $12.82M | 2.7% | $64.09 * | $44.08 | +5.6% | Call | 58933Y105 |
| — | GW PHARMACEUTICALS PLC | 125,000 | $12.53M | 2.6% | $100.25 | $100.25 | — | ADS | 36197T103 |
| — | NEVRO CORP | 165,000 | $12.28M | 2.6% | $74.43 | $74.43 | — | COM | 64157F103 |
| — | ALEXION PHARMACEUTICALS INC | 100,000 | $12.17M | 2.5% | $121.67 | $121.67 | — | COM | 015351109 |
| — | PORTOLA PHARMACEUTICALS INC | 200,000 | $11.23M | 2.3% | $56.17 | $39.19 | — | COM | 737010108 |
| — | IMMUNOMEDICS INC | 1,200,000 | $10.6M | 2.2% | $8.83 | $2.79 | — | COM | 452907108 |
| ZBH | ZIMMER BIOMET HLDGS INC | 80,000 | $10.27M | 2.1% | $128.40 * | $113.85 | -2.9% | COM | 98956P102 |
| — | GENMARK DIAGNOSTICS INC | 825,000 | $9.76M | 2.0% | $11.83 | $12.61 | — | COM | 372309104 |
| — | ENDO INTL PLC | 750,000 | $8.378M | 1.7% | $11.17 | $11.17 | — | SHS | G30401106 |
| — | JUNO THERAPEUTICS INC | 275,000 | $8.22M | 1.7% | $29.89 | $29.89 | — | COM | 48205A109 |
| INSM | INSMED INC | 475,000 | $8.151M | 1.7% | $17.16 | $17.08 | 0.0% | COM PAR $.01 | 457669307 |
| — | ACORDA THERAPEUTICS INC | 400,000 | $7.88M | 1.6% | $19.70 | $20.90 | — | COM | 00484M106 |
| — | NUVASIVE INC | 100,000 | $7.692M | 1.6% | $76.92 | $57.34 | — | COM | 670704105 |
| — | SPECTRANETICS CORP | 200,000 | $7.68M | 1.6% | $38.40 | $15.14 | — | Call | 84760C107 |
| ACAD | ACADIA PHARMACEUTICALS INC | 275,000 | $7.67M | 1.6% | $27.89 * | $34.90 | -14.6% | COM | 004225108 |
| EXEL | EXELIXIS INC | 300,000 | $7.389M | 1.5% | $24.63 | — | — | Put | 30161Q104 |
| ENTA | ENANTA PHARMACEUTICALS INC | 200,000 | $7.196M | 1.5% | $35.98 * | $31.14 | +2.7% | COM | 29251M106 |
| — | TESARO INC | 50,000 | $6.993M | 1.5% | $139.86 | $139.86 | — | COM | 881569107 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 150,000 | $6.9M | 1.4% | $46.00 * | $42.84 | +13.2% | COM | 64125C109 |
| — | NXSTAGE MEDICAL INC | 260,000 | $6.518M | 1.4% | $25.07 | $26.42 | — | COM | 67072V103 |
| — | CURRENCYSHS BRIT POUND STER | 50,900 | $6.455M | 1.3% | $126.82 | $126.82 | — | BRIT POUND STE | 23129S106 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 150,000 | $6.374M | 1.3% | $42.49 * | $36.42 | 0.0% | COM | 450056106 |
| — | INTRA CELLULAR THERAPIES INC | 500,000 | $6.21M | 1.3% | $12.42 | $15.29 | — | Call | 46116X101 |
| — | ENTELLUS MED INC | 375,000 | $6.21M | 1.3% | $16.56 | $16.60 | — | COM | 29363K105 |
| — | NOVADAQ TECHNOLOGIES INC | 500,000 | $5.86M | 1.2% | $11.72 | $7.79 | — | COM | 66987G102 |
| — | NANOSTRING TECHNOLOGIES INC | 350,000 | $5.789M | 1.2% | $16.54 | $17.11 | — | COM | 63009R109 |
| — | ALEXION PHARMACEUTICALS INC | 45,000 | $5.475M | 1.1% | $121.67 | $121.67 | — | Call | 015351109 |
| GILD | GILEAD SCIENCES INC | 75,000 | $5.309M | 1.1% | $70.79 * | $48.32 | 0.0% | COM | 375558103 |
| — | KITE PHARMA INC | 50,000 | $5.184M | 1.1% | $103.68 | — | — | Call | 49803L109 |
| — | AIMMUNE THERAPEUTICS INC | 250,000 | $5.14M | 1.1% | $20.56 | $20.56 | — | COM | 00900T107 |
| — | ATARA BIOTHERAPEUTICS INC | 350,000 | $4.9M | 1.0% | $14.00 | $14.00 | — | COM | 046513107 |
| VRAYQ | VIEWRAY INC | 750,000 | $4.853M | 1.0% | $6.47 * | $6.69 | 0.0% | COM | 92672L107 |
| BSX | BOSTON SCIENTIFIC CORP | 175,000 | $4.851M | 1.0% | $27.72 * | $19.09 | +39.0% | COM | 101137107 |
| — | AQUINOX PHARMACEUTICALS INC | 300,000 | $4.221M | 0.9% | $14.07 | $13.54 | — | COM | 03842B101 |
| ARGX | ARGENX SE | 196,287 | $4.163M | 0.9% | $21.21 | $21.21 | — | SPONSORED ADR | 04016X101 |
| — | AXOVANT SCIENCES LTD | 175,000 | $4.058M | 0.8% | $23.19 | $23.19 | — | COM | G0750W104 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 550,000 | $4.043M | 0.8% | $7.35 * | $6.36 | 0.0% | COM | 462260100 |
| — | SAGE THERAPEUTICS INC | 50,000 | $3.982M | 0.8% | $79.64 | $46.68 | — | COM | 78667J108 |
| BCRX | BIOCRYST PHARMACEUTICALS | 675,000 | $3.753M | 0.8% | $5.56 * | $4.04 | +50.7% | COM | 09058V103 |
| — | CYMABAY THERAPEUTICS INC | 650,000 | $3.744M | 0.8% | $5.76 | $4.64 | — | COM | 23257D103 |
| PTCT | PTC THERAPEUTICS INC | 200,000 | $3.666M | 0.8% | $18.33 * | $12.10 | +11.3% | COM | 69366J200 |
| — | K2M GROUP HLDGS INC | 150,000 | $3.654M | 0.8% | $24.36 | $20.51 | — | COM | 48273J107 |
| — | NEOS THERAPEUTICS INC | 500,000 | $3.65M | 0.8% | $7.30 | $7.30 | — | COM | 64052L106 |
| — | BLUEPRINT MEDICINES CORP | 70,000 | $3.547M | 0.7% | $50.67 | $39.99 | — | COM | 09627Y109 |
| — | RIGEL PHARMACEUTICALS INC | 1,100,000 | $3.003M | 0.6% | $2.73 | $2.62 | — | COM NEW | 766559603 |
| — | ALDER BIOPHARMACEUTICALS INC | 250,000 | $2.863M | 0.6% | $11.45 | $11.45 | — | COM | 014339105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 200,000 | $2.794M | 0.6% | $13.97 * | $11.43 | 0.0% | COM | 87164F105 |
| — | ACCELERON PHARMA INC | 90,000 | $2.735M | 0.6% | $30.39 | $26.38 | — | COM | 00434H108 |
| — | INTRA CELLULAR THERAPIES INC | 200,000 | $2.484M | 0.5% | $12.42 | $15.29 | — | COM | 46116X101 |
| IRIX | IRIDEX CORP | 250,000 | $2.473M | 0.5% | $9.89 | $14.17 | -30.5% | COM | 462684101 |
| — | REVANCE THERAPEUTICS INC | 89,295 | $2.357M | 0.5% | $26.40 | $26.40 | — | COM | 761330109 |
| — | EPIZYME INC | 150,000 | $2.265M | 0.5% | $15.10 | $13.15 | — | COM | 29428V104 |
| — | QUOTIENT LTD | 300,000 | $2.208M | 0.5% | $7.36 | $7.36 | — | SHS | G73268107 |
| — | SPARK THERAPEUTICS INC | 35,000 | $2.091M | 0.4% | $59.74 | $51.96 | — | COM | 84652J103 |
| — | RA PHARMACEUTICALS INC | 85,000 | $1.593M | 0.3% | $18.74 | $19.76 | — | COM | 74933V108 |
| — | ZOGENIX INC | 100,000 | $1.45M | 0.3% | $14.50 | $11.21 | — | COM NEW | 98978L204 |
| — | AUDENTES THERAPEUTICS INC | 50,000 | $957K | 0.2% | $19.14 | $19.14 | — | COM | 05070R104 |
| — | FOAMIX PHARMACEUTICALS LTD | 125,000 | $580K | 0.1% | $4.64 | $10.31 | — | SHS | M46135105 |